TR199700956T1 - Indazolkarboksamidler. - Google Patents

Indazolkarboksamidler.

Info

Publication number
TR199700956T1
TR199700956T1 TR97/00956T TR9700956T TR199700956T1 TR 199700956 T1 TR199700956 T1 TR 199700956T1 TR 97/00956 T TR97/00956 T TR 97/00956T TR 9700956 T TR9700956 T TR 9700956T TR 199700956 T1 TR199700956 T1 TR 199700956T1
Authority
TR
Turkey
Prior art keywords
indazole carboxamides
carboxamides
indazole
receptor
indazolcarboxamides
Prior art date
Application number
TR97/00956T
Other languages
English (en)
Inventor
Thomas Catlow John
Lois Cohen Marlene
John Martinelli Michael
Mehnert Schaus John
Philip Swanson Steven
Charles Thompson Dennis
Michael Wilson Thomas
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/485,956 external-priority patent/US5654320A/en
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR199700956T1 publication Critical patent/TR199700956T1/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Paper (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Luminescent Compositions (AREA)

Abstract

Indazolkarboksamidler, serotonin reseptörü 5-HT4 için antagonistler veya agonistler olarak kullanilirlar ve 5-HT4 reseptörünün görevini yapmamasinin neden oldugu veya bundan etkilenen hastaliklarin tedavisi için törapatik yöntemler saglar.
TR97/00956T 1995-03-16 1996-03-14 Indazolkarboksamidler. TR199700956T1 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40511995A 1995-03-16 1995-03-16
US08/485,956 US5654320A (en) 1995-03-16 1995-06-07 Indazolecarboxamides

Publications (1)

Publication Number Publication Date
TR199700956T1 true TR199700956T1 (tr) 1998-02-21

Family

ID=27018928

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/00956T TR199700956T1 (tr) 1995-03-16 1996-03-14 Indazolkarboksamidler.

Country Status (23)

Country Link
US (2) US5817676A (tr)
EP (1) EP0732333B1 (tr)
JP (1) JPH11502230A (tr)
CN (1) CN1112923C (tr)
AT (1) ATE203748T1 (tr)
AU (1) AU700842B2 (tr)
BR (1) BR9608223A (tr)
CA (1) CA2215359A1 (tr)
DE (1) DE69614164T2 (tr)
DK (1) DK0732333T3 (tr)
EA (1) EA000699B1 (tr)
ES (1) ES2159345T3 (tr)
GR (1) GR3037029T3 (tr)
HU (1) HU223973B1 (tr)
IL (1) IL117438A (tr)
NO (1) NO312833B1 (tr)
NZ (1) NZ315971A (tr)
PL (1) PL183867B1 (tr)
PT (1) PT732333E (tr)
RO (1) RO119617B1 (tr)
SK (1) SK283924B6 (tr)
TR (1) TR199700956T1 (tr)
WO (1) WO1996033713A1 (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
US5914405A (en) * 1997-10-07 1999-06-22 Eli Lilly And Company Process for preparing 3-substituted indazoles
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
ES2257869T3 (es) * 1998-08-21 2006-08-01 Novartis Ag Nueva formulacion oral para agonistas o antagonistas de 5-ht4.
BRPI9913542B8 (pt) 1998-09-10 2021-05-25 Hoffmann La Roche derivados de dihidrobenzodioxina carboxamida e dihidrobenzodioxina cetona como antagonistas do receptor 5-ht4 bem como composição farmacêutica, processo para a preparação dos referidos derivados e uso dos mesmos
US6743820B2 (en) 2000-07-07 2004-06-01 University Of Toledo Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor
MXPA03001210A (es) * 2000-08-07 2004-08-12 Smithkline Beecham Corp Uso de antagonista del receptor 5-ht4 en la fabricacion de un medicamento para la profilaxis o tratamiento de fibrilacion atrial.
EP1321142A1 (en) * 2001-12-21 2003-06-25 Novartis AG Solid pharmaceutical composition for oral administration of Tegaserod
JP4694129B2 (ja) 2002-02-12 2011-06-08 ナームローゼ・フエンノートチヤツプ・オルガノン 中枢神経系疾患の治療において有用な1−アリールスルホニル−3−置換インドール及びインドリン誘導体
ITMI20030287A1 (it) 2003-02-18 2004-08-19 Acraf Indazolammidi dotate di attivita' analgesica metodo, per
ITMI20031468A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco ativo nel dolore neuropatico
ITMI20031467A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco attivo nel dolore neuropatico
SE0401969D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Piperidine derivatives
EP1910340B1 (en) * 2005-07-22 2009-11-18 Pfizer, Inc. Indazolecarboxamide derivatives as 5ht4 receptor agonists
WO2009106980A2 (en) * 2008-02-29 2009-09-03 Pfizer Inc. Indazole derivatives
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145215A (en) * 1961-12-19 1964-08-18 Sterling Drug Inc Indazole derivatives
JP2795460B2 (ja) * 1988-06-20 1998-09-10 協和醗酵工業株式会社 ピラゾロアクリドン誘導体
US5017573A (en) * 1988-07-29 1991-05-21 Dainippon Pharmaceutical Co., Ltd. Indazole-3-carboxylic acid derivatives
EP0410509A1 (en) * 1989-07-25 1991-01-30 Duphar International Research B.V New substituted 1H-indazole-3-carboxamides
HU211081B (en) * 1990-12-18 1995-10-30 Sandoz Ag Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same
NZ243993A (en) * 1991-08-20 1994-10-26 Smithkline Beecham Plc Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity
CA2118798A1 (en) * 1991-09-12 1993-03-18 Francis D. King Azabicyclic compounds as 5-ht4 receptor antagonists
JPH07507290A (ja) * 1992-05-23 1995-08-10 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 不安症の治療のための医薬
JPH07508276A (ja) * 1992-06-27 1995-09-14 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 5−ht↓4受容体アンタゴニスト含有医薬品
MX9305947A (es) * 1992-09-29 1994-06-30 Smithkline Beecham Plc Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
TW251287B (tr) * 1993-04-30 1995-07-11 Nissei Co Ltd
GB9310582D0 (en) * 1993-05-22 1993-07-07 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
NO974221L (no) 1997-10-27
NZ315971A (en) 1999-01-28
ATE203748T1 (de) 2001-08-15
MX9706967A (es) 1997-11-29
BR9608223A (pt) 1998-12-29
IL117438A (en) 2001-12-23
AU6894896A (en) 1996-11-18
DK0732333T3 (da) 2001-10-08
IL117438A0 (en) 1996-07-23
EA199700242A1 (ru) 1998-04-30
WO1996033713A1 (en) 1996-10-31
NO974221D0 (no) 1997-09-12
DE69614164D1 (de) 2001-09-06
CA2215359A1 (en) 1996-10-31
SK283924B6 (sk) 2004-05-04
US5817676A (en) 1998-10-06
PL183867B1 (pl) 2002-07-31
CN1112923C (zh) 2003-07-02
EP0732333B1 (en) 2001-08-01
JPH11502230A (ja) 1999-02-23
NO312833B1 (no) 2002-07-08
HUP9801386A3 (en) 2000-03-28
RO119617B1 (ro) 2005-01-28
US5798367A (en) 1998-08-25
HUP9801386A2 (hu) 1999-06-28
HU223973B1 (hu) 2005-03-29
PT732333E (pt) 2001-11-30
AU700842B2 (en) 1999-01-14
DE69614164T2 (de) 2002-04-25
EA000699B1 (ru) 2000-02-28
ES2159345T3 (es) 2001-10-01
EP0732333A1 (en) 1996-09-18
PL322362A1 (en) 1998-01-19
SK124297A3 (en) 1998-02-04
GR3037029T3 (en) 2002-01-31
CN1183041A (zh) 1998-05-27

Similar Documents

Publication Publication Date Title
TR199700956T1 (tr) Indazolkarboksamidler.
NO964236L (no) Anvendelse av serotonin-antagonister (5HT3) for behandling av fibromyalgi
NO960630L (no) Heterocykler anvendelige som neurokinin antagonister
NO20003550D0 (no) Farmasøytiske sammensetninger og anvendelse herav
TR200101859T2 (tr) Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
FI963450A (fi) Morfoliinitakykiniinireseptoriantagonistien lääke-esiastetta
NO20010446L (no) Substituert anilidforbindelser og metoder
ATE302606T1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
TR199901172T2 (tr) Yeni ikame edilmis pirazol türevleri.
ATE478670T1 (de) Rezeptor-selektive cannabimimetische aminoalkylindole
NO963731L (no) Behandling av obsessive-kompulsive sykdommer med 5HT2-antagonister
NO944578L (no) Eksitatoriske aminosyre reseptor antagonister
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
NO994850L (no) Farmakologiske midler
NO971624D0 (no) Intracellulær isoform av interleukin-1 reseptor antagonist
DK0871446T3 (da) Anvendelse af eliprodil til fremstilling af et lægemiddel til behandling af ischaemiske sygdomme i nethinden eller den optiske nerve
YU29496A (sh) So pirolidinil metil indola
TR199800488T1 (tr) Diskinezi için 5-HT3 reseptör antagonistleri.
TR200000916T2 (tr) İkameli piperidin türevleri.